Consolidated Cash Flow Statement - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Operating Activities
Net income	$ 2,219	$ 1,066	$ 1,595
Depreciation and amortization	705	746	862
Stock-based compensation	77	75	52
Deferred income taxes	(15)	(255)	63
Equity companies' earnings (in excess of) less than dividends paid	(4)	(10)	28
Decrease (increase) in operating working capital	334	(445)	(176)
Pension and Other Postretirement Benefit Expense	(50)	930	(102)
Adjustments related to Venezuelan operations	(11)	153	462
Other	(23)	46	61
Cash Provided by Operations	3,232	2,306	2,845
Investing Activities
Capital spending	(771)	(1,056)	(1,039)
Proceeds from sales of investments	28	0	127
Investments in time deposits	(221)	(146)	(151)
Maturities of time deposits	188	164	239
Other	44	(12)	54
Cash Used for Investing	(732)	(1,050)	(770)
Financing Activities
Cash dividends paid	(1,311)	(1,272)	(1,256)
Change in short-term debt	(908)	303	721
Debt proceeds	1,293	1,100	1,257
Debt repayments	(598)	(553)	(123)
Redemption of redeemable preferred securities of subsidiary	0	0	(500)
Proceeds from exercise of stock options	107	140	127
Acquisitions of common stock for the treasury	(739)	(861)	(1,939)
Cash transferred to Halyard Health, Inc. related to spin-off	0	0	(120)
Shares purchased from noncontrolling interest	0	(151)	0
Other	(29)	(4)	(60)
Cash Used for Financing	(2,185)	(1,298)	(1,893)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(11)	(128)	(447)
Increase (Decrease) in Cash and Cash Equivalents	304	(170)	(265)
Cash and Cash Equivalents - Beginning of Year	619	789	1,054
Cash and Cash Equivalents - End of Year	$ 923	$ 619	$ 789